Details for 2018747812
Up to date per 01.04.2026
Actions
Details for 2018747812
Granted/Registered
European Patent
11.12.2019 A
12.10.2022 B1
10.07.2017
US
201762530528 P
03.02.2017
US
201762454280 P
25.07.2017
US
201762536669 P
A61K 31/437 20060101AFI20210112BHEP
Owner
Ovid Therapeutics Inc1460 Broadway New York, New York 10036US
Representative
Authorized Recipients
Dipl.-Ing. Yorck Hernandezc/o HERNANDEZ IP, Ludwig-Ganghofer-Straße 4282031 GrünwaldDE
Inventor
DURING, Matthew14 Cedar Lane Weston, Connecticut 06883US
Information about Fees